Ten years of progress in vaccination against cancer: the need to counteract cancer evasion by dual targeting in future therapies

A Decade of Progress in Lymphoma: Advances and Continuing Challenges

(2011) Christopher R. Flowers et al.   Clinical Lymphoma Myeloma & Leukemia

Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia

(2010) P. G. Maslak et al.   BLOOD

Adoptive Cell Therapy

(2010) Richard A. Morgan et al.   CANCER JOURNAL

Antibody-Dependent Natural Killer Cell-Mediated Cytotoxicity Engendered by a Kinase-Inactive Human HER2 Adenovirus-Based Vaccination Mediates Resistance to Breast Tumors

(2010) C. Triulzi et al.   CANCER RESEARCH

Epigenetic aberrations and therapeutic implications in gliomas

(2010) Atsushi Natsume et al.   CANCER SCIENCE

Immunity to stemness genes in human cancer

(2010) Madhav V Dhodapkar   CURRENT OPINION IN IMMUNOLOGY

DNA vaccines against cancer come of age

(2010) Freda K Stevenson et al.   CURRENT OPINION IN IMMUNOLOGY

Rituximab

(2010) Gillian M. Keating   DRUGS

Mechanisms of resistance to HER family targeting antibodies

(2010) Tim J. Kruser et al.   EXPERIMENTAL CELL RESEARCH

Enhancement of NK cell antitumor responses using an oncolytic parvovirus

(2010) Rauf Bhat et al.   INTERNATIONAL JOURNAL OF CANCER

Long-term follow-up of patients with resected pancreatic cancer following vaccination against mutant K-ras

(2010) Synne Wedén et al.   INTERNATIONAL JOURNAL OF CANCER

Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia

(2010) William G. Wierda et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates

(2010) Julie R. Brahmer et al.   JOURNAL OF CLINICAL ONCOLOGY

Generation of Th1-Polarizing Dendritic Cells Using the TLR7/8 Agonist CL075

(2010) S. Spranger et al.   JOURNAL OF IMMUNOLOGY

Targeting the epidermal growth factor receptor (HER) family by T cell receptor gene-modified T lymphocytes

(2010) Peter Meyerhuber et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial

(2010) Håkan Norell et al.   Journal of Translational Medicine

Plasma Membrane Proteomics and Its Application in Clinical Cancer Biomarker Discovery

(2010) Rikke Leth-Larsen et al.   MOLECULAR & CELLULAR PROTEOMICS

Development trends for human monoclonal antibody therapeutics

(2010) Aaron L. Nelson et al.   NATURE REVIEWS DRUG DISCOVERY

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Immunotherapy of Cancer: Key Findings and Commentary on the Third Tegernsee Conference

(2010) D. Ruttinger et al.   ONCOLOGIST

Everolimus (RAD001) in the Treatment of Advanced Renal Cell Carcinoma: A Review

(2010) S. S. Agarwala et al.   ONCOLOGIST

Agonist Anti-GITR Monoclonal Antibody Induces Melanoma Tumor Immunity in Mice by Altering Regulatory T Cell Stability and Intra-Tumor Accumulation

(2010) Adam D. Cohen et al.   PLoS One

An Essential Developmental Checkpoint for Production of the T Cell Lineage

(2010) T. Ikawa et al.   SCIENCE

Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein- 

(2010) M. Kraman et al.   SCIENCE

Programming tumor-reactive effector memory CD8+ T cells in vitro obviates the requirement for in vivo vaccination

(2009) C. A. Klebanoff et al.   BLOOD

Generation of CD8+ T cell-mediated immunity against idiotype-negative lymphoma escapees

(2009) B. Varghese et al.   BLOOD

Alterations of HLA class I expression in human melanoma xenografts in immunodeficient mice occur frequently and are associated with higher tumorigenicity

(2009) Cristina Garrido et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Testing the theory of immune selection in cancers that break the rules of transplantation

(2009) Ariberto Fassati et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer

(2009) Barbara Seliger et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Monoclonal Antibody-Mediated Targeting of CD123, IL-3 Receptor α Chain, Eliminates Human Acute Myeloid Leukemic Stem Cells

(2009) Liqing Jin et al.   Cell Stem Cell

Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma

(2009) A. Ribas et al.   CLINICAL CANCER RESEARCH

Improving the efficacy of cancer immunotherapy

(2009) J. Copier et al.   EUROPEAN JOURNAL OF CANCER

Development of a Wilms' tumor antigen-specific T-cell receptor for clinical trials: engineered patient's T cells can eliminate autologous leukemia blasts in NOD/SCID mice

(2009) S.-A. Xue et al.   HAEMATOLOGICA

Phase 1 Trial of Allogeneic Gene-Modified Tumor Cell Vaccine RCC-26/CD80/IL-2 in Patients with Metastatic Renal Cell Carcinoma

(2009) Alexander Buchner et al.   HUMAN GENE THERAPY

PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+CD25Hi regulatory T cells

(2009) Wenshi Wang et al.   INTERNATIONAL IMMUNOLOGY

Histone deacetylase inhibitors: Potential in cancer therapy

(2009) P.A. Marks et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Phase II Multicenter Trial of Maintenance Biotherapy After Induction Concurrent Biochemotherapy for Patients With Metastatic Melanoma

(2009) Steven J. O'Day et al.   JOURNAL OF CLINICAL ONCOLOGY

Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer

(2009) Mary L. Disis et al.   JOURNAL OF CLINICAL ONCOLOGY

Different regulation of MHC Class I antigen processing components in human tumors

(2009) Barbara Seliger   Journal of Immunotoxicology

CTLA4 blockade increases Th17 cells in patients with metastatic melanoma

(2009) Erika von Euw et al.   Journal of Translational Medicine

Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma

(2009) John M. Timmerman et al.   LEUKEMIA & LYMPHOMA

Idiotype vaccination for lymphoma: moving towards optimisation

(2009) Roch Houot et al.   LEUKEMIA & LYMPHOMA

Oncolytic Viruses: Time to Compare, Contrast, and Combine?

(2009) Hardev Pandha et al.   MOLECULAR THERAPY

Lentiviral Vectors Transduce Proliferating Dendritic Cell Precursors Leading to Persistent Antigen Presentation and Immunization

(2009) Frederick Arce et al.   MOLECULAR THERAPY

In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses

(2009) Marcin Kortylewski et al.   NATURE BIOTECHNOLOGY

Amplification of immune responses against a DNA-delivered idiotypic lymphoma antigen by fusion to the B subunit of E. coli heat labile toxin

(2009) Caleb G. Chen et al.   VACCINE

Modified tumour antigen-encoding mRNA facilitates the analysis of naturally occurring and vaccine-induced CD4 and CD8 T cells in cancer patients

(2008) Ashley J. Knights et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Oxidation of Ovarian Epithelial Cancer Cells by Hypochlorous Acid Enhances Immunogenicity and Stimulates T Cells that Recognize Autologous Primary Tumor

(2008) C. L-L. Chiang et al.   CLINICAL CANCER RESEARCH

Can NK cells be a therapeutic target in human diseases?

(2008) Christopher J. Chan et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy

(2008) Rafael Carretero et al.   IMMUNOGENETICS

Antibody association with HER-2/neu–targeted vaccine enhances CD8+ T cell responses in mice through Fc-mediated activation of DCs

(2008) Peter S. Kim et al.   JOURNAL OF CLINICAL INVESTIGATION

Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin

(2008) David Sancho et al.   JOURNAL OF CLINICAL INVESTIGATION

HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance

(2008) M Campoli et al.   ONCOGENE

Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity

(2008) D. C. Palmer et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas

(2008) A. Kruschinski et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Identification of prostate cancer antigens by automated high-throughput filter immunoscreening

(2007) Lene Alsøe et al.   JOURNAL OF IMMUNOLOGICAL METHODS